Tavolixizumab (MEDI 0562, Tavolimab) is a human monoclonal antibody to TNFRSF4 (TNF receptor superfamily member 4, OX40, CD134) for use in cancer immunology research.
Purity:
>95.0%
CAS Number:
[1635395-25-3]
Target:
TNF Receptor
* VAT and and shipping costs not included. Errors and price changes excepted